abstract |
The present invention relates to single domain antibodies directed against intracellular antigens. Specifically, it relates to an anti-Ebola VP24 single domain antibody (sdAb). The present invention includes the use of the sdAbs for prophylactic, therapeutic or diagnostic purposes. |